Atlas Trials

Personalized Spacing of Eculizumab Infusions Based on Therapeutic Pharmacological Monitoring (EspacECU)

Clinical trial NCT04859608 · COMPLETED

Trial details

NCT number
NCT04859608
Sponsor
University Hospital, Tours
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Hemolytic-Uremic Syndrome, Atypical
Start date
2021-10-20
Primary completion
2022-06-16
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.